← FDA Drug Approvals (Drugs@FDA)

RYBELSUS

NDA · New Drug Application · Sponsor: NOVO NORDISK INC · Approved 2020-01-16

Drug application

FDA Application #

NDA213182

Application type

New Drug Application

Brand name

RYBELSUS

Generic name

Semaglutide

Active ingredients

SEMAGLUTIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVO NORDISK INC

First approval

2020-01-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown